This book chapter provides a thorough examination of the
isolation process, structural characterization, and pharmacological properties
of two novel depsides, Antarvedisides A and B, extracted from Dirinaria
consimilis (Stirton) D.D. Awasthi, alongside several known depsides. The study
explores the compounds' structural features and delves into their
pharmacological profile, emphasizing their potential as promising candidates
for future drug development. Chromatographic examination of acetone extract of
D. consimilis yielded Antarvedisides A and B, sekikaic acid, atranorin,
divaricatic acid and 2’-O-methyl divaricatic acid. Antioxidant activity
assessment through superoxide, DPPH and ABTS radical scavenging assays reveals
that Antarvedisides A-B and 2’-O-Methyldivaricatic acid exhibit remarkable
antiradical scavenging capacities, surpassing the standard drug, ascorbic acid.
The investigation extends to in vitro anti-inflammatory activity, where
atranorin exhibits superior inhibition against protein denaturation in
comparison to the standard drug indomethacin. Antarvedisides A-B showcases
moderate anti-inflammatory activity, further detailed with IC50 values ranging
from 878-600 µg/mL. The anticancer potential of the depsides is highlighted
through the Sulforhodamine B assay screening. Antarvediside B emerges as a
potent inhibitor of cell growth in MCF-7 and HeLa, outperforming doxorubicin.
Additionally, 2’-O-methyldivaricatic acid demonstrates significant inhibitory
profiles against various cancer cell lines. In conclusion, this abstract
summarizes the comprehensive pharmacological profile of Antarvedisides A and B,
shedding light on their antioxidant, anti-inflammatory, and anticancer
activities. These findings underscore the potential of these depsides as valuable
candidates for further drug development and contribute to the expanding
knowledge of natural compounds with therapeutic implications.
Author(s) Details
Vinay Bharadwaj
Tatipamula
Pharmaceutical Chemistry Department, AU College of
Pharmaceutical Sciences, Andhra University, Visakhapatnam – 530003, Andhra
Pradesh, India.
Girija Sastry Vedula
Pharmaceutical Chemistry Department, AU College of
Pharmaceutical Sciences, Andhra University, Visakhapatnam – 530003, Andhra
Pradesh, India.
Please see the book here:- https://doi.org/10.9734/bpi/rdcbr/v3/12824F
No comments:
Post a Comment